Article
PREFER-DMT: A Discrete Choice Experiment Framework for Eliciting Stakeholder Preferences on Disease-Modifying Therapy Implementation in European Healthcare Systems
2026-04-14
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> Health technology assessment (HTA) bodies across Europe are preparing to evaluate Alzheimer’s disease-modifying therapies (DMTs), yet no standardised framework exists for eliciting and comparing stakeholder preferences on DMT implementation across different healthcare systems. Existing discrete choice experiment (DCE) evidence on Alzheimer’s treatment prefere...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c862bab4-f5d0-5c26-badf-1b795110e0d4
- DOI
- 10.21203/rs.3.rs-9405777/v1
